An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV …
Purpose Transcatheter aortic valve replacement (TAVR) is a minimally invasive treatment for high-risk patients with aortic diseases. Despite its increasing use, many influential factors …
M Abdel-Wahab, M Simonato, A Latib… - Circulation …, 2018 - Am Heart Assoc
Background Limited data exist on clinical valve thrombosis after transcatheter aortic valve-in- valve (ViV) implantation. Our objective was to determine the incidence, timing, clinical …
A Alperi, S Garcia, J Rodes-Cabau - Progress in Cardiovascular Diseases, 2022 - Elsevier
The use of bioprosthetic valves for treating patients with severe valve disease has increased over the last 2 decades, and, as a consequence, a growing number of patients with failing …
ACT Ng, DR Holmes, MJ Mack, V Delgado… - European heart …, 2020 - academic.oup.com
Transcatheter aortic valve replacement (TAVR) has grown exponentially worldwide in the last decade. Due to the higher bleeding risks associated with oral anticoagulation and in …
Leaflet thrombosis following transcatheter aortic valve replacement (TAVR) and Valve-in- Valve (ViV) procedures has been increasingly recognized. This study aimed to investigate …
OBJECTIVES Clinical and subclinical leaflet thromboses are increasingly recognized complications following transcatheter aortic valve replacement. Identification of the risk …
HS Kandail, SD Trivedi, AC Shaikh, TK Bajwa… - Journal of the …, 2018 - Elsevier
CoreValve is widely used in transcatheter aortic valve replacement, but the impact of its deployment location on hemodynamics is unexplored despite a potential role in subsequent …
V Bapat - Annals of Cardiothoracic Surgery, 2017 - ncbi.nlm.nih.gov
Transcatheter aortic valve implantation (TAVI) has emerged as a viable treatment modality for patients with severe aortic valve stenosis and multiple co-morbidities. More recent …